Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Accutar Biotechnologyaccutarbio.com · Low evidenceAccutar Biotechnology is a U.S.-based biotech company that uses artificial intelligence to explain the physical and chemical nature of biological systems and to accelerate drug discovery. It employs a data-driven, hybrid approach combining computational drug design with wet-lab validation to cut time and costs in traditional drug development. The company offers AI-powered solutions such as ChemiRise, Orbital, Virtual Screen, Intelligent-SAR, Chemi-Net, and PatentGPT, and maintains a drug discovery pipeline with programs like AC699, along with news and collaborations.
Parse Score